NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,284,000 | +73.7% | 49,012 | +63.4% | 0.10% | +74.5% |
| Q2 2022 | $1,315,000 | -87.6% | 30,000 | -79.5% | 0.06% | -86.0% |
| Q1 2022 | $10,609,000 | +175.8% | 146,674 | +209.1% | 0.39% | +133.1% |
| Q4 2021 | $3,847,000 | +0.8% | 47,457 | +44.7% | 0.17% | -9.6% |
| Q3 2021 | $3,816,000 | +197.2% | 32,786 | +205.0% | 0.19% | +27.2% |
| Q2 2020 | $1,284,000 | -28.3% | 10,750 | -29.4% | 0.15% | -21.4% |
| Q4 2019 | $1,790,000 | – | 15,225 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |